Autoimmune hepatitis as a rare cause of cirrhosis development
DOI:
https://doi.org/10.12775/JEHS.2024.56.009Keywords
autoimmune hepatitis, cirrhosis of the liver, liver diseaseAbstract
Cirrhosis is a serious condition associated with progressive damage to this organ. Autoimmune hepatitis (AIH) is one of the causes leading to the development of cirrhosis. This disease is characterized by chronic inflammation with damage to hepatocytes and presence of specific immune markers. The diagnosis of AIH is based on biochemical, immunoserological and histopathological tests. There are defined diagnostic criteria, liver biopsy is important in determining the extent of the disease. Symptoms of AIH are nonspecific and include weight loss, fatigue, jaundice, abdominal pain and symptoms associated with the overactivity of an immune system. Advanced cases of AIH can lead to cirrhosis. AIH most often affects middle-aged women, although it can occur in people of any age. Epidemiological data indicate an increase in the incidence of AIH, which may be related to various environmental factors. The rate of progression of AIH to cirrhosis and depends on a number of factors. Effective treatment includes immunosuppression, mainly the use of glucocorticosteroids and azathioprine. Monitoring, healthy lifestyle and patient education are key. In severe cases, liver transplantation may be necessary.
References
Ginès P, Krag A, Abraldes JG, Solà E, Fabrellas N, Kamath PS. Liver cirrhosis. Lancet. 2021;398(10308):1359-1376. doi:10.1016/S0140-6736(21)01374-X
Krzysztof Gutkowski, Marek Hartleb Autoimmune hepatitis https://podyplomie.pl/wiedza/wielka-interna/781,autoimmunologiczne-zapalenie-watroby#Obraz_kliniczny
Komori A. Recent updates on the management of autoimmune hepatitis. Clin Mol Hepatol. 2021;27(1):58-69. doi:10.3350/cmh.2020.0189
Liberal R, Longhi MS, Mieli-Vergani G, Vergani D. Pathogenesis of autoimmune hepatitis. Best Pract Res Clin Gastroenterol. 2011;25(6):653-664. doi:10.1016/j.bpg.2011.09.009
Sucher E, Sucher R, Gradistanac T, Brandacher G, Schneeberger S, Berg T. Autoimmune Hepatitis-Immunologically Triggered Liver Pathogenesis-Diagnostic and Therapeutic Strategies. J Immunol Res. 2019;2019:9437043. Published 2019 Nov 25. doi:10.1155/2019/9437043
Gatselis NK, Zachou K, Koukoulis GK, Dalekos GN. Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics. World J Gastroenterol. 2015;21(1):60-83. doi:10.3748/wjg.v21.i1.60
Tan CK, Ho D, Wang LM, Kumar R. Drug-induced autoimmune hepatitis: A minireview. World J Gastroenterol. 2022;28(24):2654-2666. doi:10.3748/wjg.v28.i24.2654
Kim BH, Choi HY, Ki M, Kim KA, Jang ES, Jeong SH. Population-based prevalence, incidence, and disease burden of autoimmune hepatitis in South Korea. PLoS One. 2017;12(8):e0182391. Published 2017 Aug 3. doi:10.1371/journal.pone.0182391
Tanaka A, Mori M, Matsumoto K, Ohira H, Tazuma S, Takikawa H. Increase trend in the prevalence and male-to-female ratio of primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis in Japan. Hepatol Res. 2019;49(8):881-889. doi:10.1111/hepr.13342
Grønbæk L, Vilstrup H, Jepsen P. Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study. J Hepatol. 2014;60(3):612-617. doi:10.1016/j.jhep.2013.10.020
Shrestha M, Subedi SC, Shah S, Acharya J, Regmi M, Mehta N. Autoimmune Hepatitis Leading to Liver Cirrhosis: A Case Report. JNMA J Nepal Med Assoc. 2022;60(256):1059-1062. Published 2022 Dec 1. doi:10.31729/jnma.7808
Lohse AW, Mieli-Vergani G. Autoimmune hepatitis. J Hepatol. 2011;55(1):171-182. doi:10.1016/j.jhep.2010.12.012
Stravitz RT, Lefkowitch JH, Fontana RJ, et al. Autoimmune acute liver failure: proposed clinical and histological criteria. Hepatology. 2011;53(2):517-526. doi:10.1002/hep.24080
Czaja AJ. Performance parameters of the conventional serological markers for autoimmune hepatitis. Dig Dis Sci. 2011;56(2):545-554. doi:10.1007/s10620-010-1501-1
Zhou WC, Zhang QB, Qiao L. Pathogenesis of liver cirrhosis. World J Gastroenterol. 2014;20(23):7312-7324. doi:10.3748/wjg.v20.i23.7312
Roehlen N, Crouchet E, Baumert TF. Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells. 2020;9(4):875. Published 2020 Apr 3. doi:10.3390/cells9040875
Sharma B, John S. Hepatic Cirrhosis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; October 31, 2022.
Feng S, Tu H, Chen L. A novel model predicted liver cirrhosis constructed by ultrasound and serological in autoimmune liver hepatitis. Medicine (Baltimore). 2023;102(38):e35295. doi:10.1097/MD.0000000000035295
Liberal R, Krawitt EL, Vierling JM, Manns MP, Mieli-Vergani G, Vergani D. Cutting edge issues in autoimmune hepatitis. J Autoimmun. 2016;75:6-19. doi:10.1016/j.jaut.2016.07.005
Dean L. Azathioprine Therapy and TPMT and NUDT15 Genotype. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kattman BL, Malheiro AJ, eds. Medical Genetics Summaries. Bethesda (MD): National Center for Biotechnology Information (US); September 20, 2012.
Manns MP, Lohse AW, Vergani D. Autoimmune hepatitis--Update 2015. J Hepatol. 2015;62(1 Suppl):S100-S111. doi:10.1016/j.jhep.2015.03.005
Woynarowski M, Nemeth A, Baruch Y, et al. Budesonide versus prednisone with azathioprine for the treatment of autoimmune hepatitis in children and adolescents. J Pediatr. 2013;163(5):1347-53.e1. doi:10.1016/j.jpeds.2013.05.042
Manns MP, Czaja AJ, Gorham JD, et al. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010;51(6):2193-2213. doi:10.1002/hep.23584
Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D. Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments. World J Gastroenterol. 2017;23(33):6030-6048. doi:10.3748/wjg.v23.i33.6030
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Dominika Podgórska, Karolina Jurasz, Miłosz Sanecki, Karolina Tomczyk, Natalia Chojnacka, Ewa Rzeska, Jakub Klarycki, Radosław Cymer
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 232
Number of citations: 0